Sonic Healthcare holds AGM after posting strong FY25 growth and reaffirming FY26 outlook

A group of people in a corporate setting do a collective high five.

The Sonic Healthcare Ltd (ASX: SHL) share price is in focus after the company reaffirmed its FY26 earnings guidance and posted 8% revenue and EBITDA growth for FY2025.

What did Sonic Healthcare report in FY25?

  • Statutory revenue for FY2025 rose 8% year-over-year to A$9,645 million
  • EBITDA increased by 8% to A$1,725 million
  • Net profit climbed 7% to A$514 million
  • Earnings per share improved by 6% to 106.7 cents
  • Total FY2025 dividends of $1.07 per share, up 1% on the prior year
  • Cash generated from operations jumped 21% to A$1,297 million

What else do investors need to know?

Sonic Healthcare confirmed its FY26 EBITDA guidance range of A$1.87–1.95 billion (on constant currency), targeting up to 13% growth on FY25. Year-to-date statutory revenue as of October 2025 grew 17%, with organic revenue up 5%, supported by recent acquisitions and contract wins.

The company completed the acquisition of LADR Laboratory Group in Germany, marking a significant milestone. This deal, partly funded by issuing new Sonic shares, is expected to deliver immediate earnings per share accretion and strong returns after synergies.

What’s next for Sonic Healthcare?

Looking ahead, Sonic Healthcare expects first-half weighting for FY2026 earnings to follow historical patterns, after an atypical FY2025. The company plans to sustain organic growth through innovation in pathology and diagnostics as well as pursue further targeted acquisitions.

Management is focused on controlling costs, boosting earnings per share, and extracting value from recent acquisitions, while maintaining a progressive dividend policy supported by ongoing strong cash flows.

Sonic Healthcare share price snapshot

Over the past 12 months, Sonic shares have fallen 23%, underperforming the S&P/ASX 200 Index (ASX: XJO) which has risen 1% over the same period.

View Original Announcement

The post Sonic Healthcare holds AGM after posting strong FY25 growth and reaffirming FY26 outlook appeared first on The Motley Fool Australia.

Should you invest $1,000 in Sonic Healthcare Limited right now?

Before you buy Sonic Healthcare Limited shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Sonic Healthcare Limited wasn’t one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys…

* Returns as of 18 November 2025

.custom-cta-button p {
margin-bottom: 0 !important;
}

More reading

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Sonic Healthcare. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *